Bronchiolitis: Clinical Trials

2 trials for Bronchiolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 2

Follow Bronchiolitis: new trials by email Literature Review of Bronchiolitis trials Research Report on Bronchiolitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of MED HF10™ Spinal Cord Stimulation for the Treatment of Chronic Pain
SCS Device Program Setting - Chronic, Intractable Back Pain and/or Leg Pain
Phase 4Active not recruitingNevro Corp252021-11-162026-06-29
CINC424A2X01B Rollover Protocol
ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera
Phase 4Active not recruitingNovartis Pharmaceuticals2792015-03-052026-10-19

Narrower conditions

Bronchiolitis Obliterans Syndrome (2)  ·  Graft vs Host Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Polycythemia Vera (1)  ·  Primary Myelofibrosis (1)  ·  Thalassemia (1)

Broader conditions

Bronchial Diseases (2)  ·  Bronchiolitis Obliterans (2)  ·  Bronchitis (2)  ·  Immune System Diseases (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Organizing Pneumonia (2)  ·  Respiratory Tract Diseases (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Neoplasms (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Panobinostat (1)  ·  ruxolitinib (1)

Sponsors

Nevro Corp (1)  ·  Novartis Pharmaceuticals (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)

Top investigators

Mayank Gupta, MD (1)

NIH funding

2014 (1)